When you care about wellness as a whole, you look beyond weight
Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
For individuals who have struggled with conventional weight loss methods, these advanced peptide therapies represent a potential turning point
In subjects with a higher baseline BMI (above 40 kg/m), the percentage body weight reduction observed at each retatrutide dose may translate to a larger absolute kilogram loss
Women of childbearing potential should use effective contraception during treatment and discuss preconception planning and any required washout period with their trial team or clinician before attempting to conceive
Glycine exhibits inhibitory neurotransmitter activity in the central nervous system
